Statement_of_Work_Radiopharmaceutical_Contract.docx
DOCX document 22 KB Posted
- Attached to
- Radiopharmaceutical Supplies Federal contract opportunity
- Solicitation number
- N68095-15-T-3002
View the file
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
STATEMENT OF WORK
Delivery Requirements:
1. All radiopharmaceuticals can only be received by Nuclear Medicine and Radiology personnel and will be directly delivered to Nuclear Medicine Clinic and stored in room 3305.
2. Delivery of routine radiopharmaceutical and pharmaceutical orders will be delivered no later than 0730 on the required date, Monday through Friday as specified on the delivery order.
3. Emergency orders placed during normal working hours will be delivered within one (1) hour of order placement.
4. Emergency orders placed after normal working hours, including weekends, holidays and evenings, will be delivered within two (2) hours of order placement.
5. All white blood cells (WBC)-labeled items regardless of normal or emergency status must be completed and returned to the Naval Hospital within five (5) hours after taking custody of the patient’s blood specimen.
6. All personnel delivering the packages must maintain a current RapidGate badge to gain access to Naval Hospital Bremerton.
Radiopharmaceutical Requirements:
1. A current copy of the contractor’s radioactive materials permit will be provided to Naval Hospital Bremerton.
2. Radionuclide purity testing will be performed by the contractor on all radiopharmaceuticals except WBC-labeled items prior to delivery and a copy of the radio-purity report will be provided annually. All products must meet the manufacturer’s minimum radiopharmaceutical requirements. Molybdenum-99 (Mo-99) contamination (breakthrough) will not exceed 0.15 uCi of Mo-99 per 1mCi of Tc-99m at the time of administration. The maximum permissible amount of aluminum ion is 10 ug/mL of Tc-99m eluate.
3. No product substitution will be allowed without prior approval of Designated Authority at Naval Hospital Bremerton.
4. All unit dose amounts will be specified by Naval Hospital Bremerton. Radiopharmaceuticals will be assayed for activity before delivery and the dose accuracy must be within with +/- 10% of the specified dosage at the time of administration, except for iodine-131 capsules, which must be with +/- 5% of the specified dose. Radiopharmaceuticals will be calibrated and labeled for their estimated time use.
5. Technetium-99m (Tc-99m) macroaggregated albumin (MAA) doses will not exceed the product insert maximum suggested number of particles. The number of particles provided will be reduced to 100,000-200,000 when the radiopharmacy is notified that the dose will be administered to a patient with known pulmonary hypertension or right-to-left shunt.
Invoicing Requirements:
1. Invoices will be submitted to Wide Area Work Flow monthly in arrears with their delivery slips.
2. All orders will be placed orally and as needed by the Nuclear Medicine staff of Naval Hospital Bremerton.
3. Delivered radiopharmaceuticals will not be billed if the delivered dosage does not fall within 20 percent of the ordered dosage at the ordered calibration time and date.
Estimated radiopharmaceutical supplies for the period of 01 October 2015 through 30 September 2016 to include:
**Radioactive**
| Quantity |
| Technetium |
| Product |
| Description |
| 10 |
| Tc-99m |
| DTPA |
| Unit Dose |
| 10 |
| Tc-99m |
| DMSA |
| Unit Dose |
| 25 |
| Tc-99m |
| HDP |
| Unit Dose |
| 10 |
| Tc-99m |
| MAA |
| Unit Dose |
| 14 |
| Tc-99m |
| MAG3 |
| Unit Dose |
| 98 |
| Tc-99m |
| MDP |
| Unit Dose |
| 25 |
| Tc-99m |
| Mebrofenin |
| Unit Dose |
| 12 |
| Tc-99m |
| MUGA |
| Unit Dose |
| 364 |
| Tc-99m |
| Sestamibi |
| Unit Dose |
| 365 |
| Tc-99m |
| Source uCi |
| Unit Dose |
| 20 |
| Tc-99m |
| Sulfur Colloid |
| Unit Dose |
| 30 |
| Tc-99m |
| Sulfur Colloid (filtered) |
| Lympho |
| 50 |
| Tc-99m |
| TcO4 (pertechnetate) |
| Per mCi (Bulk) |
| I-123 (200 uCi) |
| Capsule |
| I-131 Therapy (15 mCi) |
| Capsule |
| Thallium-201 |
| Unit Dose |
| WBC (HMPAO) |
| Labeling |
*Non-Radioactive*
Quantity
| Product |
| Description |
| Kinevac |
| Vial |
| Ultratag RBC |
| Vial-Kit |
File details come from the government source that posted it. Updated .